Latest
California's new shoplifting laws take effect
Key measures include extending probation for shoplifting to two years, enabling longer monitoring of offenders, and expanding arrest powers for law enforcement.
Dove invites women to redefine New Year's resolutions
Dove launches its first-ever body confidence series for women.
Nature Made helps pharmacists refuel & reset with free lunch during National Pharmacist Day
Company giving away $50,000 in free lunches to pharmacists with “Fuel for Pharmacists Powered by Nature Made”
Eli Lilly enters FDA dispute over drug shortages
Eli Lilly defends its blockbuster medications in a case with industry-wide implications.
Cloud Haircare launching in CVS
A new era in haircare begins January 3rd at CloudHaircare.com and CVS.
Currax rolls out CONTRAVE TV spot and "Cravings Don't Own Me" campaign, highlighting food cravings management and weight loss
The new campaign empowers individuals to take advantage of their weight-loss journey and the constant thoughts of food and uncontrolled food cravings that can be a barrier to achieving a healthy weight.
Thrifty White and SureCost renew partnership for independent pharmacies
The partnership renewal brings innovative solutions to help affiliated pharmacies navigate a complex pharmacy landscape.
Unisom and Saquon Barkley team to tackle sleepless nights
Playful campaign brings relief to fans losing sleep over Barkley's milestone season with lullabies, sheep, and Unisom.
Camber launches new IBS medication
This medication serves the needs of patients managing functional bowel disorders and IBS.
CRN: Flawed study on prenatal vitamins fuels misplaced anxiety among pregnant women
Proper application of USP standards confirms safe levels.
McKesson Corp. completes divestiture of Canada-based Rexall and Well.ca businesses
Birch Hill acquired the drugstore chain from McKesson Corp. in a transaction that closed Dec. 30.
Lilly’s Zepbound holds potential to dominate obesity market
Recently, Eli Lilly announced the results from its SURMOUNT-5 trial, comparing Zepbound and Wegovy’s efficacy on equal grounds.
Appriss: Fraudulent returns and claims cost retailers $103B in 2024
The report reveals no signs of returns fraud slowing down.
RXBAR challenges 'New Year, New You' in new billboard campaign
The campaign features a B.S. Blocker Truck, bold billboards, and sparks a social conversation to reject unrealistic expectations.
Global Data forecasts Type 1 diabetes market to reach $9.9 billion by 2033
"According to primary research conducted by GlobalData, high volumes of prescribing physicians and patients have demonstrated positive attitudes towards the use of ultra-rapid insulin analogs, which is expected to drive T1D market growth.”